China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Inventory Average of $1.6 million for Q1 2026, up 219.53% year-over-year from $511184.0 in Q1 2025, and up 135.23% quarter-over-quarter from $694378.5 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Inventory Average (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Inventory Average rose 219.53% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 219.53% YoY), while the FY2026 annual figure was $1.2 million, up 126.31% from the prior year.
- Inventory Average for Q1 2026 stood at $1.6 million, up from $694378.5 in the prior quarter.
- The five-year high for Inventory Average was $1.6 million in Q1 2026, with the low at $294691.0 in Q1 2023.
- The 5-year median for Inventory Average is $537827.5 (2022), against an average of $661826.7.
- The sharpest annual moves came in 2023 and 2026: Inventory Average slumped 62.01% in 2023, then soared 219.53% in 2026.
- China SXT Pharmaceuticals' Inventory Average stood at $537827.5 in 2022, then sank by 42.42% to $309678.5 in 2023, then soared by 144.8% to $758086.5 in 2024, then fell by 8.4% to $694378.5 in 2025, then jumped by 135.23% to $1.6 million in 2026.
- Business Quant data shows SXTC's Inventory Average at $1.6 million in Q1 2026, $694378.5 in Q3 2025, and $511184.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | China SXT Pharmaceuticals | 32,442.83 | -28.14 Mn | - | 764,202.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 Mn |
| Sep 30, 2025 | 694,378.50 |
| Mar 31, 2025 | 511,184.00 |
| Sep 30, 2024 | 758,086.50 |
| Mar 31, 2024 | 441,479.00 |
| Sep 30, 2023 | 309,678.50 |
| Mar 31, 2023 | 294,691.00 |
| Sep 30, 2022 | 537,827.50 |
| Mar 31, 2022 | 775,711.00 |
| Sep 30, 2021 | 696,795.50 |
| Mar 31, 2021 | 671,357.00 |
| Sep 30, 2020 | 687,892.50 |
| Mar 31, 2020 | 586,854.50 |
| Sep 30, 2019 | 644,430.00 |
| Mar 31, 2019 | 665,169.00 |
| Sep 30, 2018 | 794,650.00 |